Memantine-induced bradycardia - A rare adverse reaction

Abstract

Behavioural and psychological symptoms of dementia, such as aggression or agitation are very frequent in Alzheimer’s disease with most guidelines recommending memantine as first-line pharmacological treatment. Here, the authors describe a patient who developed bradycardia when prescribed memantine and the subsequent changes required to her medication management to avoid further cardiac adverse reactions.